Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 2771 - 2780 of 132111 results

First page
Previous page
Next page
Next page

Lingdolinurad

QSN2XMW3TI

Search for Structure

Status:

Investigational

Source:

INN:lingdolinurad [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/QSN2XMW3TI

Class (Stereo):

CHEMICAL (ACHIRAL)

BALCINRENONE

6C9UKZ0CYE

Search for Structure

Status:

Investigational

Source:

INN:balcinrenone [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/6C9UKZ0CYE

Class (Stereo):

CHEMICAL (ABSOLUTE)

DYNORPHIN A 1-13

VFC23V742Z

Search for Structure

Status:

Investigational

Source:

NCT00000244: Phase 2 Interventional Completed Opioid-Related Disorders

(1994)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00000244

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Delta opioid receptor

Mu opioid receptor

Kappa opioid receptor

Vociprotafib

C4YBF9170L

Search for Structure

Status:

Investigational

Source:

INN:vociprotafib [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/C4YBF9170L

Class (Stereo):

CHEMICAL (ABSOLUTE)

SEBRIPLATIN

GZ8I2X2FZK

Search for Structure

Status:

Investigational

Source:

INN:sebriplatin

Source URL:

https://tripod.nih.gov/npc/#Download

Class (Stereo):

CHEMICAL (ABSOLUTE)

Sebriplatin (also known as NK-121 or CI-973) is a platinum analog with antitumor activity. Sebriplatin participated in phase II clinical trials for the treatment of patients with metastatic breast cancer. However, the further development of this drug was discontinued.

Mosnodenvir

5EJO0RJF9O

Search for Structure

Status:

Investigational

Source:

INN:mosnodenvir [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/5EJO0RJF9O

Class (Stereo):

CHEMICAL (ABSOLUTE)

VIPIVOTIDE TETRAXETAN GALLIUM GA-68

7P5C02S4X8

Search for Structure

Status:

Investigational

Source:

NCT03606837: Phase 2 Interventional Recruiting Prostate Cancer

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03606837

Class (Stereo):

CHEMICAL (ABSOLUTE)

OMILANCOR

A4Y49H6YY8

Search for Structure

Status:

Investigational

Source:

INN:omilancor [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/A4Y49H6YY8

Class (Stereo):

CHEMICAL (ACHIRAL)

Camlipixant

TB7D2H7MZZ

Search for Structure

Status:

Investigational

Source:

INN:Camlipixant [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/TB7D2H7MZZ

Class (Stereo):

CHEMICAL (ABSOLUTE)

6-6-DIDEUTEROGLUCOSE

W8HHU8ES4E

Search for Structure

Status:

Investigational

Source:

NCT04311307: Phase 1/Phase 2 Interventional Completed Glycogen Storage Disease Type IA

(2021)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04311307

Class (Stereo):

CHEMICAL (ABSOLUTE)

Structure of Lingdolinurad

ACHIRAL

Structure of BALCINRENONE

ABSOLUTE

Structure of DYNORPHIN A 1-13

ABSOLUTE

DYNORPHIN A 1-13

Structure of Vociprotafib

ABSOLUTE

Structure of SEBRIPLATIN

ABSOLUTE

Structure of Mosnodenvir

ABSOLUTE

Structure of VIPIVOTIDE TETRAXETAN GALLIUM GA-68

ABSOLUTE

VIPIVOTIDE TETRAXETAN GALLIUM GA-68

Structure of OMILANCOR

ACHIRAL

Structure of Camlipixant

ABSOLUTE

Structure of 6-6-DIDEUTEROGLUCOSE

ABSOLUTE

6-6-DIDEUTEROGLUCOSE

Showing 2771 - 2780 of 132111 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1